Indeed, a tubular adenocarcinoma showed homogeneous FGFR2 amplification in the primary tumor while the corresponding lymph node metastasis showed no FGFR2 amplification. This evidence concerns the gene FGFR2 and gastric tubular adenocarcinoma.